{
  "id": 5549738,
  "title": "Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets",
  "url": "https://urgent.news/2026/09/04/thiel-backed-lindus-sells-cro-arm-in-pivot-to-hunt-for-drug-assets",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T12:00:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/thiel-backed-lindus-sells-cro-arm-in-pivot-to-hunt-for-drug-assets/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Peter Thiel-backed transatlantic startup that once branded itself as an “anti-CRO” is pivoting from a clinical trials operator to a drug developer. Lindus Therapeutics is betting that its experience over ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}